$VICR

Schmidt James F sold $65K of VICR

Schmidt James F (CFO, Treasurer, Secretary) sold 200 shares of VICOR CORP (VICR) at $325.68 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schmidt James F
Published Jun 2, 2026, 5:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 5:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
high confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because the trade is pre-arranged, it generally carries less immediate informational content than unscheduled selling; it is unlikely to reset valuation expectations without corroborating fundamental news.

02

Market read

Routine insider selling disclosure; potential minor sentiment noise but no standalone catalyst.

03

What to watch

The filing doesn’t state total insider exposure changes beyond the post-transaction share count; compare with prior Form 4 patterns for context.

Relevance 6/10Novelty 2/10Timing: Filed today; sale executed 2026-06-01 under a 10b5-1 plan.

Background

This is an SEC Form 4 insider transaction disclosure for ViCOR Corp (CFO/Treasurer/Secretary) showing an open-market sale executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

ViCOR Corp disclosed an officer/director open-market sale of 200 shares at $325.68 under a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term price impact; any reaction is likely muted unless accompanied by unusual volume or additional disclosures.

Evidence & confidence

The article provides only a routine Form 4 sale detail (size, price, and 10b5-1 pre-arrangement) with no accompanying company-specific operational or financial news.

Market effects

No clear sector read-through from a single, pre-arranged insider sale.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with management views on near-term risk; traders may still watch for follow-on sales or larger transactions.

Key entities

  • VICOR CORP

    Public company subject of the insider transaction disclosure.

  • Schmidt James F

    CFO/Treasurer/Secretary; sold 200 shares on 2026-06-01 under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: